Advertisement

Central European Journal of Medicine

, Volume 9, Issue 5, pp 609–618 | Cite as

Determinants of changes in lipid levels in a prophylactic programme

  • Irena Maniecka-BryłaEmail author
  • Aleksandra Maciak-Andrzejewska
  • Marek Bryła
Research Article
  • 43 Downloads

Abstract

Introduction

The aim of this study was to evaluate changes in the levels of certain lipids in a group of participants in the Prophylaxis and Early Detection of Cardiovascular Diseases Programme and also to determine factors contributing to positive changes in the variables.

Materials and methods

The study was conducted in Zgierz, a town in central Poland. 458 people, former participants of the Prophylaxis and Early Detection of Cardiovascular Diseases Programme, were included in the study. The study tool was a questionnaire. The authors made laboratory tests to determine the lipid profile and serum glucose. They also took arterial pressure twice and made anthropometric measurements. The authors used single-factor logistic regression to evaluate the obtained results. They adopted statistical significance level of p<0.05. The data were presented as odds ratios (OR) with 95% confidence intervals (CIs).

Results

A positive change in TC levels was observed in 64% of the respondents, LDL cholesterol level in 47.8% and HDL cholesterol level in 60.7%. In 46.5% of the respondents, a decrease in the level of triglycerides was observed.

Conclusions

There is a need to initiate prophylactic activities, especially among males, people who are less educated and also among older people.

Keywords

Prophylaxis programmes on cardiovascular diseases Lipid balance Poland 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. [1]
    Maniecka-Bryła I., Pikala M., Bryła M., Life years lost due to cardiovascular diseases. Kardiol. Pol. 2013, 71, 293–300Google Scholar
  2. [2]
    Maniecka-Bryła I., Pikala M., Bryła M., Health inequalities among rural and urban inhabitants of Łódź province, Poland. Ann. Agric. Environ. Med. 2012, 19, 723–731Google Scholar
  3. [3]
    Maniecka-Bryła I, Maciak-Andrzejewska A, Bryła M, Bojar I, An assessment of health effects of a cardiological prophylaxis programme in a local community with the use of the SCORE algorithm. Ann. Agric. Environ. Med. 2013. 20,794–799PubMedGoogle Scholar
  4. [4]
    Mckee M., Perry I., Ischaemic heart disease — more than just lipids. Eur. J. Public Health 2002, 12, 241–242PubMedCrossRefGoogle Scholar
  5. [5]
    Bryła M., Maciak-Andrzejewska A., Maniecka-Bryła I., Częstość wybranych czynników ryzyka chorób układu krążenia w zależności od charakteru wykonywanej pracy. Med. Pr. 2013, 64, 307–315PubMedGoogle Scholar
  6. [6]
    Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report. Circulation 2002, 106, 3143–3421Google Scholar
  7. [7]
    Pająk A., Wiercińska E., Polakowska M., Kozakiewicz K., Kaczmarczyk-Chałas K., Tykarski A. i in., Rozpowszechnienie dyslipidemii u mężczyzn i kobiet w wieku 20–74 lata w Polsce. Wyniki programu WOBASZ. Kardiol. Pol. 2005, 63,supl. 4, 1–4Google Scholar
  8. [8]
    Zdrojewski T., Bandosz P., Szpakowski P. Konarski R., Manikowski A., Wołkiewicz E. i in., Rozpowszechnienie głównych czynników ryzyka chorób układu sercowo-naczyniowego w Polsce. Wyniki badania NATPOL PLUS. Kardiol. Pol. 2004, 61,supl. 1, 1–26Google Scholar
  9. [9]
    Mastej M., Jóźwiak J., Lukas W. Piwowarska W., Tykarski A., Orzechowski M., Ocena i porównanie parametrów lipidogramu w zależności od płci oraz wskaźnika masy ciała BMI. Kardiol. Pol. 2006, 64, supl. 2, 153–160Google Scholar
  10. [10]
    Ministry of Health — National Health Plan for years 2004–2013. Warsaw, Poland, 2003; 262–263Google Scholar
  11. [11]
    Narodowy Program Zdrowia 2007–2015, Ministerstwo Zdrowia, Warszawa 2007Google Scholar
  12. [12]
    Lorezno C., Williams K., Hunt K. Haffner S.M., The National Cholesterol Education Program — Adult Treatment Panel III, International Diabetes Federation, and World Health Organization Definitions of the Metabolic Syndrome as Predictors of Incident Cardiovascular Disease and Diabetes. Diabetes Care, 2007, 30, 8–13CrossRefGoogle Scholar
  13. [13]
    Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report. Circulation, 2002, 106, 3143Google Scholar
  14. [14]
    Arnett D.K., Jacobs D.R., Luepker R.V., Blackburn H,, Armstrong C, Claas S.A., Twenty-Year Trends in Serum Cholesterol, Hypercholesterolemia, and Cholesterol Medication Use: The Minnesota Heart Survey, 1980–1982 to 2000–2002. Circulation 2005, 112, 3884–3891PubMedCrossRefGoogle Scholar
  15. [15]
    Rysz J., Banach M., Stolarek R., Irzmański R., Markuszewski L., Wilk R., The lipid disorders therapy in overweight patients. Arch. Med. Sci. 2005, 1, 241–245Google Scholar
  16. [16]
    Batic-Mujanovic O., Beganlic A., Salihefendic N. Pranjic N., Kusljugic Z., Influence of smoking on serum lipid and lipoprotein levels among family medicine patients. Med. Arh. 2008, 62, 264–267PubMedGoogle Scholar
  17. [17]
    Nakamura K., Barzi F., Huxley R., Lam T.H., Suh I., Woo J. et. al., Asia Pacific Cohort Studies Collaboration: Does cigarette smoking exacerbate the effect of total cholesterol and high-density lipoprotein cholesterol on the risk of cardiovascular diseases? Heart, 2009, 95, 909–916PubMedCrossRefGoogle Scholar
  18. [18]
    Noguchi Y., Fukui T., The effects of cessation from cigarette smoking on the lipid and lipoprotein pro- files: a meta-analysis. Prev. Med. 2003. 37. 283–90PubMedCrossRefGoogle Scholar
  19. [19]
    Piper M.E., Johnson H.M., Fiore M.C., Baker T.B., Stein J.H., Effects of smoking and smoking cessation on lipids and lipoproteins: outcomes from a randomized clinical trial. Am. Heart J. 2011, 161, 145–151PubMedCentralPubMedCrossRefGoogle Scholar
  20. [20]
    De Miguel-Díez J., Carrasco-Garrido P., Rejas-Gutierrez J. Martín-Centeno A., Gobartt-Vázquez E., Hernandez-Barrera V., et al., The influence of heart disease on characteristics, quality of life, use of health resources, and costs of COPD in primary care settings. Cardiovascular Disorders, 2010, 10, 8–17PubMedCentralPubMedCrossRefGoogle Scholar
  21. [21]
    European Hearth Health Charter — European Society of Cardiology and the European Heart Network; Brussels 2007: 10Google Scholar
  22. [22]
    Kirkwood L., Aldujaili E., Drummond S., Effects of advice on dietary intake and/or physical activity on body composition, blood lipids and insulin resistance following a low-fat, sucrose-containing, highcarbohydrate, energy-restricted diet. Int. J. Food Sci. Nutr. 2007, 58, 383–397PubMedCrossRefGoogle Scholar
  23. [23]
    Ainslie P.N., Reilly T., Maclaren D.P., Campbell I.T., Changes in plasma lipids and lipoproteins following 10-days of prolonged walking: influence of age and relationship to physical activity level. Ergonomics 2005. 48, 1352–1364PubMedCrossRefGoogle Scholar
  24. [24]
    Skoumas J., Pitsavos C., Panagiotakos D.B., Chrysohoou C., Zeimbekis A., Papaioannou I., et al., Physical activity, high density lipoprotein cholesterol and other lipids levels, in men and women from the ATTICA study. Lipids in Health and Disease, 2003, 2, 3–11PubMedCentralPubMedCrossRefGoogle Scholar
  25. [25]
    Pelletier D.L., Baker P.T., Physical activity and plasma total- and HDL-cholesterol levels in Western Samoan men. AJCN 1987, 46, 577–585Google Scholar
  26. [26]
    Gordon L., Ragoobirsingh D., Morrison E., McGrowder D., Choo-Kang E., Martorell E., Dyslipidaemia in hypertensive obese type 2 diabetic patients in Jamaica. Arch. Med. Sci. 2010, 6, 701–708PubMedCentralPubMedCrossRefGoogle Scholar

Copyright information

© Versita Warsaw and Springer-Verlag Berlin Heidelberg 2014

Authors and Affiliations

  • Irena Maniecka-Bryła
    • 1
    Email author
  • Aleksandra Maciak-Andrzejewska
    • 1
  • Marek Bryła
    • 1
  1. 1.Department of Epidemiology and BiostatisticsMedical University of LodzLodzPoland

Personalised recommendations